At the same time, we conducted survival analysis on the existing data and found that among glioblastoma patients, patients with low TPPP3 expression had a longer progression-free survival (Fig. 6C), and the overall survival rate was higher than that of the high TPPP3 group (Fig. 6D). This evidence concerns the gene TPPP3 and glioblastoma.